Changsong Lin
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in
- Rheumatology 15
- Rheumatoid Arthritis Research and Therapies 12
- Systemic Lupus Erythematosus Research 4
-
- Autoimmune and Inflammatory Disorders Research 5
- Co-authors
- Qiang Xu (27 shared papers)Qingping Liu (8 shared papers)Minying Liu (7 shared papers)Yubao Jiang (2 shared papers)Xiaobao Liu (7 shared papers)Zhenquan Wei (2 shared papers)Nan Li (1 shared paper)Nan Li (2 shared papers)
- Journals
- International Immunopharmacology (4 papers)Frontiers in Pharmacology (3 papers)Phytomedicine (2 papers)Frontiers in Immunology (2 papers)Clinical Rheumatology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Changsong Lin
35 papers receiving 375 citations
Peers
Comparison fields: 5 of 68
- Rheumatology 137
- Pharmacology 56
- Drug Discovery 1
- Complementary and alternative medicine 29
- Immunology 54
Countries citing papers authored by Changsong Lin
This map shows the geographic impact of Changsong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changsong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changsong Lin more than expected).
Fields of papers citing papers by Changsong Lin
This network shows the impact of papers produced by Changsong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changsong Lin. The network helps show where Changsong Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Changsong Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 102 | |
| 2 | 2017 | 59 | |
| 3 | 2016 | 32 | |
| 4 | 2018 | 28 | |
| 5 | 2024 | 13 | |
| 6 | 2023 | 13 | |
| 7 | [Multi-center clinical study on therapeutic effect of kunxian capsule on rheumatoid arthritis]. | 2011 | 12 |
| 8 | 2023 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2024 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2024 | 8 | |
| 14 | Plasma D-dimer is a Promising Indicator for the Treatment of Acute Gouty Attack. | 2018 | 6 |
| 15 | 2022 | 5 | |
| 16 | 2019 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2023 | 4 |
About Changsong Lin
Changsong Lin is a scholar working on Rheumatology, Hematology, Nephrology, Molecular Biology and Genetics, having authored 37 papers that have together received 379 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (12 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Systemic Lupus Erythematosus Research (4 papers), Acupuncture Treatment Research Studies (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Rheumatology (137 citations), Pharmacology (56 citations), Drug Discovery (1 citation), Complementary and alternative medicine (29 citations) and Immunology (54 citations). Changsong Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qiang Xu, Qingping Liu, Minying Liu, Yubao Jiang, Xiaobao Liu, Zhenquan Wei, Nan Li, Nan Li, Hanshi Xu and Tianfeng Guo. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Phytomedicine, Frontiers in Immunology and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.